Former executives of the pharmaceutical giant are backing a push by activist investor Starboard Value to turn aro ...

Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist investor’s $1bn stake in the pharmaceutical group puts pressure on its board ...

Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing ...

The BofA wealth unit's latest additions in Texas and New York reportedly oversee nearly $900M in client assets combined. This expansion indicates a positive trend in the investment industry, as more ...

Pfizer Inc.’s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug ...

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

A federal judge ordered the tech giant to let rival app stores onto its Android smartphone platform, adding to its growing ...

Key Takeaways Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...

Starboard Value, an activist investment firm, has taken a significant $1 billion stake in Pfizer, signaling its intent to ...